18:38 〜 19:00

[2S13e-05] Efficacy of Eflornithine/Sulindac combination against SARS-CoV-2 infection

^〇Natalia A. Ignatenko¹, Hien Trinh², April M. Wagner³, Chiu-Hsieh Hsu⁴, David G. Besselsen³ (1.Arizona Cancer Center, 2.Valley Fiver Center for Excellence, 3.University Animal Care, 4.College of Public Health, University of Arizona, Tucson, AZ)

キーテクノロジー：Translational Science

SARS-CoV-2、Eflornithine、Sulindac、mouse model